United Therapeutics Corporation (Nasdaq: UTHR) has initiated legal action against the United States Food and Drug Administration (FDA), as announced today. The litigation centers on United Therapeutics’ claim that the FDA erroneously allowed Liquidia Corporation (Liquidia) to circumvent established FDA…
AskBio Initiates Phase II Gene Therapy Trial for Heart Failure Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a subsidiary of Bayer AG, have announced the randomization of the first patient in GenePHIT (Gene PHosphatase Inhibition Therapy), a Phase II trial…
Bio-Rad’s 2023 Financial Results Announced Today, Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a prominent figure in life science research and clinical diagnostics, unveiled its financial results for the fourth quarter and full year ending December 31, 2023. In the…
Forecast for Global Retinal Surgery Device Markets (2022-2030) – Company Profiles, Major Deals, Strategies, and Recent Developments The report on the Global Retinal Surgery Devices Market, including Device Segments, Applications, Regional Analysis, Company Profiles, Major Deals, Strategies, and Recent Developments,…
GE HealthCare Tech Inc. Prices 13M Share Secondary Offering GE HealthCare Technologies Inc. (Nasdaq: GEHC) announced the pricing of its previously announced secondary underwritten public offering (the “Offering”) of 13,000,000 shares of its common stock (the “GEHC Shares”) at a…
Healthcare Data Interoperability: Opportunities & Forecast to 2028 – Moving Towards Semantic Interoperability – ResearchAndMarkets.com The “Global Healthcare Data Interoperability Forecast to 2028” report is now available on ResearchAndMarkets.com. Interoperability in Healthcare: Trends, Challenges, and Opportunities Interoperability in healthcare refers…
FDA Clears Xolair as Sole Treatment for Food Allergies in Children and Adults Genentech, a member of the Roche Group, disclosed today that the U.S. Food and Drug Administration (FDA) has granted approval for Xolair® (omalizumab) to mitigate allergic reactions,…
TAGRISSO® and Chemotherapy Combo Approved for EGFR-Mutated Lung Cancer AstraZeneca’s TAGRISSO® (osimertinib) combined with chemotherapy has secured approval in the US for treating adult patients with locally advanced or metastatic epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC).…
Henry Schein Launches ‘Prevention is Power’ Campaign Henry Schein, Inc. (Nasdaq: HSIC) unveils Prevention is Power™, a long-term public health awareness initiative led by the Henry Schein Cares Foundation, Inc. (HSCF). This campaign aims to enhance health literacy and encourage…
On Wednesday, Feb. 14, Ambetter from Sunshine Health joined forces with the Miami Dolphins to combat food insecurity in South Florida, providing essential food assistance to local families in need. Volunteers from Ambetter and the Miami Dolphins teamed up to…
Missouri Schools & Home State Health: Fostering Belonging on National No One Eats Alone® Day For the sixth consecutive year, Home State Health, a Managed Care Organization catering to Medicaid recipients in collaboration with MO HealthNet and a subsidiary of…
Meridian in Michigan, a prominent managed care organization and subsidiary of Centene Corporation (NYSE: CNC), has teamed up with the Wayne Mobile Health Unit (WMHU) to enhance maternal and infant health. This partnership extends support to WMHU’s community outreach initiatives,…